Cargando…

Testing COVID-19 therapies to prevent progression of mild disease

Detalles Bibliográficos
Autores principales:	Lipsitch, Marc, Perlman, Stanley, Waldor, Matthew K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202831/ https://www.ncbi.nlm.nih.gov/pubmed/32618282 http://dx.doi.org/10.1016/S1473-3099(20)30372-8

Ejemplares similares

Estimating case fatality rates of COVID-19
por: Lipsitch, Marc
Publicado: (2020)

Azithromycin for mild-to-moderate COVID-19
por: Patel, Jigar, et al.
Publicado: (2021)

Post-acute COVID-19 outcomes in children with mild and asymptomatic disease
por: Say, Daniela, et al.
Publicado: (2021)

Thrombocytopenia in pregnant patients with mild COVID-19
por: Le Gouez, A., et al.
Publicado: (2020)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Predominance of visuoconstructive impairment after mild COVID-19?
por: Díez-Cirarda, María, et al.
Publicado: (2022)

Mild Pancreatic Enzyme Elevations in COVID-19 Pneumonia: Synonymous With Injury or Noise?
por: Ashok, Aditya, et al.
Publicado: (2021)

Is COVID in Neonates Really Mild?
por: Khamkar, Anilkumar M., et al.
Publicado: (2021)

Modified oxygen therapy device for prevention of aerosol dispersion in COVID-19 patients
por: Kumar, Amarjeet, et al.
Publicado: (2020)

Prevention and Control of COVID-19 in Chronic Kidney Disease: Correspondence
por: Kalra, Suprita
Publicado: (2020)

Management of mild cases of COVID-19 in low-resource countries: An experience in Vietnam
por: Than, Hung Manh, et al.
Publicado: (2021)

Clinical, Imaging, and Histopathological Features of Pulmonary Sequelae after Mild COVID-19
por: Gagiannis, Daniel, et al.
Publicado: (2023)

Comment on “Clinical Dementia Rating Orientation Score as an Excellent Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment”
por: Kawada, Tomoyuki
Publicado: (2018)

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
por: An, Ping, et al.
Publicado: (2020)

The necessity of early anti-inflammatory therapy initiation in cases with mild-to-moderate COVID-19: A personal experience from an attending pharmacist and his resident
por: Parisa, Ghasemiyeh, et al.
Publicado: (2021)

Prevention of the cytokine storm in COVID-19
por: Wright, David J M
Publicado: (2021)

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020)

Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19
por: Ceulemans, Laurens J, et al.
Publicado: (2021)

Impaired systemic oxygen extraction long after mild COVID-19: potential perioperative implications
por: Heerdt, Paul M., et al.
Publicado: (2022)

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
por: De Angelis, Marcello, et al.
Publicado: (2020)

Reply to “Predominance of visuoconstructive impairment after mild COVID-19?” by Díez-Cirarda et al. 2022
por: de Paula, Jonas J., et al.
Publicado: (2022)

‘Test, re-test, re-test’: using inaccurate tests to greatly increase the accuracy of COVID-19 testing
por: Ramdas, Kamalini, et al.
Publicado: (2020)

Use of protease inhibitors for the prevention of COVID-19
por: Sagawa, Tomoya, et al.
Publicado: (2020)

Suicide prevention during the COVID-19 outbreak
por: Klomek, Anat Brunstein
Publicado: (2020)

Preventing major outbreaks of COVID-19 in jails
por: Okano, Justin T, et al.
Publicado: (2020)

Progressive respiratory failure in COVID-19: a hypothesis
por: Endeman, Henrik, et al.
Publicado: (2020)

Unnecessary obstacles to COVID-19 mass testing
por: Peto, Julian, et al.
Publicado: (2020)

Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab
por: Guevara, Carlos, et al.
Publicado: (2020)

Poliomyelitis in the United States during COVID-19 and monkeypox outbreak: Totally vaccine preventable diseases?
por: Dayyab, Farouq Muhammad
Publicado: (2022)

Health and medicine cannot solve COVID-19
por: McLennan, Amy K, et al.
Publicado: (2020)

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
por: Bowles, Louise, et al.
Publicado: (2020)

COVID-19 and improved prevention of hospital-acquired infection
por: Hu, Ling-Qun, et al.
Publicado: (2020)

The preventive strategies of COVID-19 pandemic in Saudi Arabia
por: Nurunnabi, Mohammad
Publicado: (2021)

CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance
por: Bakhtiyari, Maryam, et al.
Publicado: (2023)

Coronary microvascular dysfunction in patients with mild-to-moderate aortic stenosis – Insights from intracoronary acetylcholine testing
por: Martínez Pereyra, Valeria, et al.
Publicado: (2020)

Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)
por: Cure, Erkan, et al.
Publicado: (2020)

Mild trauma surgery has decreased due to the COVID-19 pandemic
por: Fujioka, Masaki, et al.
Publicado: (2022)

Effects of coronavirus disease 2019 (COVID-19), including its prevention and treatment, on the male reproductive system
por: Liu, Kai, et al.
Publicado: (2021)

UK food system resilience tested by COVID-19
por: Moran, Dominic, et al.
Publicado: (2020)

Is NHS Test and Trace exacerbating COVID-19 inequalities?
por: Briggs, Adam D M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g5l2r3v3o54corhj5rn1ijbn74